Ravi Karan Patti
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ravi Karan Patti has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Saumya Nanda
Maimonides Medical Center
2 shared publications - Tharun Shyam
Maimonides Medical Center
2 shared publications - Yan Naing Tun
Maimonides Medical Center
2 shared publications Momna Noor
Maimonides Medical Center
1 shared publicationNavjot Somal
Maimonides Medical Center
1 shared publication- Omair Ali Khan
Department of Rheumatology, University of Nebraska Medical Center, Nebraska, USA
1 shared publication
Latest Publications
- Open Access
- 19 January 2026
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 16 (1) , 52-55
Disguised and Dangerous: A Case of Cervicofacial Actinomycosis presenting with Hemoptysis
Actinomycosis is a rare, chronic, suppurative bacterial infection caused by Actinomyces spp with an incidence of 0.3 cases per million people annually. The cervicofacial area is the most common site of infection and accounts for approximately 50 percent of all cases. Most cases of cervicofacial actinomycosis are odontogenic in origin. Hemoptysis in the setting of actinomycosis commonly occurs from pulmonary involvement. Hemoptysis secondary to isolated cervicofacial actinomycosis has seldom been documented in literature. We hereby present a case of cervicofacial actinomycosis presenting with hemoptysis likely secondary to an oro-cervical fistula. We aim to highlight the challenges in diagnosis of this relatively rare clinical entity and the potential for life threatening complications if not detected and managed appropriately
- 19 January 2026
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 16 (1) , 52-55
Open AccessDisguised and Dangerous: A Case of Cervicofacial Actinomycosis presenting with Hemoptysis
Actinomycosis is a rare, chronic, suppurative bacterial infection caused by Actinomyces spp with an incidence of 0.3 cases per million people annually. The cervicofacial area is the most common site of infection and accounts for approximately 50 percent of all cases. Most cases of cervicofacial actinomycosis are odontogenic in origin. Hemoptysis in the setting of actinomycosis commonly occurs from pulmonary involvement. Hemoptysis secondary to isolated cervicofacial actinomycosis has seldom been documented in literature. We hereby present a case of cervicofacial actinomycosis presenting with hemoptysis likely secondary to an oro-cervical fistula. We aim to highlight the challenges in diagnosis of this relatively rare clinical entity and the potential for life threatening complications if not detected and managed appropriately
- Open Access
- 3 July 2025
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 15 (4) , 88-91
WALKING PNEUMONIA - NOT ALWAYS SO TIMID A CASE OF SEVERE ARDS DUE TO FULMINANT MYCOPLASMA PNEUMONIA
Mycoplasma pneumoniae pneumonia (MPP) most commonly presents as bronchitis or as a self-limited ‘walking’ community acquired pneumonia. A fulminant form of MPP may occur in 0.5% to 2% of patients and is characterized by rapidly progressive respiratory failure and Acute respiratory distress syndrome (ARDS). Our case highlights the importance of considering fulminant MPP as a cause of ARDS, especially in the young adult and middle-aged population. We review the current literature and management principles of this rare disease with an emphasis on antibiotic stewardship and corticosteroid therapy. Further research is needed to better understand patterns of antibiotic resistance and to establish management guidelines for fulminant MPP.
- 3 July 2025
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 15 (4) , 88-91
Open AccessWALKING PNEUMONIA - NOT ALWAYS SO TIMID A CASE OF SEVERE ARDS DUE TO FULMINANT MYCOPLASMA PNEUMONIA
Mycoplasma pneumoniae pneumonia (MPP) most commonly presents as bronchitis or as a self-limited ‘walking’ community acquired pneumonia. A fulminant form of MPP may occur in 0.5% to 2% of patients and is characterized by rapidly progressive respiratory failure and Acute respiratory distress syndrome (ARDS). Our case highlights the importance of considering fulminant MPP as a cause of ARDS, especially in the young adult and middle-aged population. We review the current literature and management principles of this rare disease with an emphasis on antibiotic stewardship and corticosteroid therapy. Further research is needed to better understand patterns of antibiotic resistance and to establish management guidelines for fulminant MPP.